These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 34231314)
1. The dietary supplement chitosan lowers serum phosphorus in a hemodialysis patient not tolerating prescription medications. Quinn V; Graber J; Sedlacek M Hemodial Int; 2022 Jan; 26(1):E12-E15. PubMed ID: 34231314 [TBL] [Abstract][Full Text] [Related]
2. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use. Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640 [TBL] [Abstract][Full Text] [Related]
3. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model. Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review. Gasu V; Ashong M; Seferi A; Fitzpatrick A JBI Database System Rev Implement Rep; 2019 Jan; 17(1):49-73. PubMed ID: 30204711 [TBL] [Abstract][Full Text] [Related]
5. The adequacy of phosphorus binder prescriptions among American hemodialysis patients. Huml AM; Sullivan CM; Leon JB; Sehgal AR Ren Fail; 2012; 34(10):1258-63. PubMed ID: 23013171 [TBL] [Abstract][Full Text] [Related]
6. Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status. Lopes AA; Tong L; Thumma J; Li Y; Fuller DS; Morgenstern H; Bommer J; Kerr PG; Tentori F; Akiba T; Gillespie BW; Robinson BM; Port FK; Pisoni RL Am J Kidney Dis; 2012 Jul; 60(1):90-101. PubMed ID: 22385781 [TBL] [Abstract][Full Text] [Related]
13. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. Spiegel DM; Farmer B; Smits G; Chonchol M J Ren Nutr; 2007 Nov; 17(6):416-22. PubMed ID: 17971314 [TBL] [Abstract][Full Text] [Related]
14. Salivary glands: a new player in phosphorus metabolism. Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917 [TBL] [Abstract][Full Text] [Related]
15. Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders. Noto L J Ren Nutr; 2011 May; 21(3):277-82. PubMed ID: 20598905 [TBL] [Abstract][Full Text] [Related]